COPD is a general term used to describe progressive lung diseases like emphysema and chronic bronchitis.
COPD leads to decreased airflow in the lungs over time, as well as inflammation and narrowing of the airway walls. Inflammation is the local response of the body to cell injury, characterized by irritation and thickening of the airways.
COPD may start with mild symptoms or even no symptoms. As the disease gradually builds up over time, symptoms usually worsen. Common signs and symptoms of COPD include:
Remember, not everyone with these symptoms has COPD, and not everyone with COPD has these symptoms. Make sure you keep track of your symptoms and how they’re affecting your daily life. And be sure to keep your doctor informed.
COPD: SYMBICORT 160/4.5 mcg is used long-term to improve symptoms of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, for better breathing and fewer flare-ups.
Asthma: SYMBICORT is for the treatment of asthma in patients 6 years and older whose asthma is not well-controlled with an asthma-control medicine such as an inhaled corticosteroid (ICS) or whose asthma warrants treatment with both an ICS and a long-acting beta2-adrenergic agonist (LABA).
SYMBICORT is not used to relieve sudden breathing problems and will not replace a rescue inhaler.Please see full Prescribing Information and Patient Information, and discuss with your doctor.
You may report side effects related to AstraZeneca products by clicking here.
This site is intended for US consumers only.
The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about SYMBICORT, asthma, or COPD, talk to your doctor or pharmacist. Only you and your doctor can decide if SYMBICORT is right for you.